• To Speed Sequencing, Edico Genome Proposes NGS Processor

    Bio-IT World | Of sequencing bottlenecks, the most lamented is the analysis pipeline. Edico Genome is developing the DRAGEN Bio-IT Processor, the world’s first Next Generation Sequencing (NGS) bioinformatics ASIC to speed and smooth that process.

    Apr 21, 2014
  • Remarkable Twin Study Widens View of Down's Syndrome

    Bio-IT World News Brief | A large coalition of European and American researchers this week published a new gene expression study of trisomy 21, better known as Down's syndrome, using a novel cellular model of the disorder.

    Apr 18, 2014
  • As Genetics Moves to the Clinic, Pathogenic Variants Still Subject to Doubt and Debate

    Bio-IT World | Genetic diagnostics is a growing field with great promise for improving medical care—yet interpreting the results of tests is a painstaking process, and different labs can disagree on which variants contribute to disease. As open science advocates seek to collect together and curate our knowledge of disease-related genes, the reluctance of many clinical labs to share their data continues to hinder progress.

    Apr 17, 2014
  • Novartis Out of RNAi Research

    Forbes | Novartis bows out of RNAi research, the second big pharma to do so.

    Apr 15, 2014
  • Broad Claims Patent on CRISPR Technology

    Bio-IT World News Brief | The U.S. Patent and Trademark Office this morning issued the first patent to cover CRISPR-Cas9 gene editing, awarding the Broad Institute a patent for a version of the CRISPR-Cas9 system used to modify the DNA of mammalian cells.

    Apr 15, 2014
  • In Last Sprint to Product Launch, Edico Genome Hints at Massively Accelerated Informatics

    U-T San Diego | San Diego-based Edico Genome is working on a chip-based system, the Dragen Wavefront Processor, to perform first-line analysis of genetic information in a fraction of the time required by the fastest current methods.

    Apr 14, 2014
  • Bio-Rad Picks Up GnuBIO, Droplet-Based Sequencing

    Bio-IT World News Brief | Bio-Rad has acquired GnuBIO, a next-generation droplet-based DNA sequencing technology. GnuBIO's DNA sequencing solution integrates the entire sample preparation workflow on a chip.

    Apr 11, 2014
  • Duke's Plans for the Soon-to-be Defunct Institute for Genome Sciences

    Duke Chronicle | Duke's plans for the Institute for Genome Sciences & Policy were made public in late March--a formal dismantling July 1.

    Apr 10, 2014
  • FDA Grants Breakthrough Status to Gene Therapy for First Time

    Bio-IT World News Brief | Celladon today became the first company to receive breakthrough status for a gene therapy treatment in development. The treatment, MYDICAR, is intended to reduce the risk of heart failure in patients with a deficiency of the enzyme SERCA2a.

    Apr 10, 2014